Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Equity Method Investment, Realized Gain (Loss) on Disposal	$ (398.0)	$ 0.0
Cash flows from operating activities:
Net earnings	1,289.9	444.3
Discontinued operations, net of tax	(34.3)	23.4
Adjustments for non-cash transactions:
Depreciation and amortization	264.7	269.2
Changes in assets and liabilities, net	(212.6)	(550.8)
Other non-cash items, net	98.4	94.1
Net cash provided by (used in) continuing operating activities	1,008.3	280.2
Net cash provided by (used in) discontinued operating activities	94.1	(27.2)
Net cash provided by (used in) operating activities	1,102.4	253.0
Cash flows from investing activities:
Capital expenditures	(127.5)	(173.3)
Acquisition of businesses, net of cash acquired	(9.2)	(952.0)
Proceeds from sale of property, plant and equipment	2.6	14.8
Proceeds from Sale of Equity Method Investments	423.0	0.0
Net cash provided by (used in) continuing investing activities	288.4	(1,110.5)
Cash flows from financing activities:
Short-term borrowings (payments), net	(150.6)	362.8
Payments of long-term debt	0.0	(23.7)
Net proceeds (repayments) in debt	(150.6)	339.1
Dividends paid to ordinary shareholders	(245.6)	(227.4)
Dividends paid to noncontrolling interests	(13.8)	(9.0)
Repurchase of ordinary shares	(250.1)	(233.4)
Other, net	30.6	54.6
Net cash provided by (used in) continuing financing activities	(631.6)	(76.1)
Effect of exchange rate changes on cash and cash equivalents	8.6	(120.1)
Net increase (decrease) in cash and cash equivalents	767.8	(1,053.7)
Cash and cash equivalents - beginning of period	736.8	1,705.2
Cash and cash equivalents - end of period	$ 1,504.6	$ 651.5